摘要
目的探讨生物共振治疗系统治疗慢性荨麻疹的临床疗效及安全性。方法将患者随机分为3组,治疗组61例,采用生物共振治疗系统进行脱敏治疗;对照组59例口服咪唑斯汀(皿治林)10mg,qd,连续用3周;联合治疗组32例,采用生物共振治疗系统脱敏治疗同时加口服咪唑斯汀(皿治林)10mg,qd,连用3周。结果3组治疗有效率比较差异有显著性(P<0.05),其中联合治疗组与治疗组及对照组比较均有显著差异(P<0.05),治疗组与对照组比较无显著性差异(P>0.05)。3组复发率比较差异有显著性(P<0.001)。结论生物共振技术治疗慢性荨麻疹有一定的疗效和安全性,且复发率低,尤其联合治疗可提高疗效。
Objective： To determine the clinical efficacy and safety of bicom - bioresonnace therapy in patients with chronic urticaria. Methods： The patients were randomly divided into three groups. The first group （61 cases） were treated with bicom- bioresonnace therapy alone, the second group （59 cases） with mizolastine 10mg dally for three weeks and the third group （32 cases） with the combination of the two therapies. Results： There were significant differences in response rate between the three groups（ P 〈 0.05 ）, among them the third group had significant difference as compared with the first and second groups （ P 〈 0.05）. The difference did not reach the statistically significant level between the first and the second groups （ P 〉 0.05）. There were statistically significant differences between the three groups（ P 〈 0.001 ） in the recurrence rate. Conclusion： Bicom- bioresonnace therapy was useful in the treatment of chronic urticaria with few side effects and low recurrence rate. Especially, the combined therapy can improve the clinical efficacy.
出处
《中国麻风皮肤病杂志》
2006年第4期280-282,共3页
China Journal of Leprosy and Skin Diseases
关键词
生物共振
荨麻疹
脱敏治疗
bieom- bioresonnaee therapy
urticaria
dehypersensitivitv therapy
